---
title: "Prevalence and causes of secondary psychosis in adults with first-episode psychosis in Hong Kong"
id: "medrxiv-15-secondary-causes-among-adult-patients-presenting-with-first-episode-psychosis"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-15-secondary-causes-among-adult-patients-presenting-with-first-episode-psychosis"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.02.26362044v1?rss=1"
published_at: "2026-09-04T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Prevalence and causes of secondary psychosis in adults with first-episode psychosis in Hong Kong
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-15-secondary-causes-among-adult-patients-presenting-with-first-episode-psychosis
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.02.26362044v1?rss=1)
- **Published At:** 2026-09-04T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective review examined adults aged 18–64 with **first-episode psychosis (FEP)** referred to consultation psychiatry at a tertiary acute teaching hospital in Hong Kong between January 2015 and April 2025. - The cohort included 384 patients (mean age 40.0 ± 13.7 years; 69% female). Patients with delirium were excluded. - **Secondary causes** of psychosis were identified in 9.6% (n = 37) of the cohort. - **Substance use** was the single most common secondary cause overall (n = 11; 2.9% of all FEP presentations). - In 16 patients with secondary psychoses, the underlying condition was revealed only by medical workup performed because of the FEP presentation. - Among those conditions uncovered by FEP-related workup, **autoimmune encephalitis** (definitive or probable) was identified in five patients and **early-onset dementia** in four patients; these were the most frequent diagnoses detected by investigation. - The authors report that the observed prevalence of secondary psychoses in this Hong Kong FEP cohort is lower than published international figures. - The study highlights the need for clinicians to recognise clinical features that raise suspicion for **autoimmune encephalitis** and **early-onset dementia** in FEP patients with otherwise unremarkable history and toxicology. - Ethical approval was obtained from the Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee. Data are available on request. No competing interests were declared.
## Clinical Analysis & Structured Key Points
Secondary causes among adult patients presenting with first-episode psychosis to acute medical settings in Hong Kong: A 10-Year retrospective study | medRxiv Skip to main content Secondary causes among adult patients presenting with first-episode psychosis to acute medical settings in Hong Kong: A 10-Year retrospective study View ORCID Profile Steven Wai Ho Chau , Lam KW Lam , Matthew PM Yu , Yuen Cheuk Wong , Joseph CC Choi , Howan HW Leung doi: https://doi.org/10.64898/2026.09.02.26362044 Steven Wai Ho Chau 1 The Chinese University of Hong Kong; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Steven Wai Ho Chau For correspondence: stevenwaihochau{at}cuhk.edu.hk Lam KW Lam 2 Department of Psychiatry, Prince of Wales Hospital, Hong Kong; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Matthew PM Yu 3 Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yuen Cheuk Wong 4 Department of General Adult Psychiatry, Castle Peak Hospital, Hong Kong, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joseph CC Choi 5 Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Howan HW Leung 6 5. Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background The prevalence and pattern of secondary causes of first-onset psychosis (FEP) in Asian populations are understudied. Our objectives are to investigate the prevalence and pattern of secondary causes of FEP presenting in an acute medical setting in a metropolitan, Chinese-predominant population, and to investigate the prevalence and pattern of undiagnosed conditions presenting as psychosis. Method This is a retrospective observational study. We reviewed medical records of patients referred to the consultation psychiatry team at a tertiary acute teaching hospital in Hong Kong from January 2015 to Apr 2025. The inclusion criteria of the study are 1) age 18-64 at the time of the assessment, and 2) FEP confirmed by the consultation liaison team. Patients diagnosed with delirium were excluded. Result Among the 384 patients included in the study (mean age = 40.0 ±13.7 years, 69% female), secondary causes of psychosis were found in 9.6% (n=37) of the cohort. Substance use is the most common secondary cause found (n=11, 2.9% of all FEPs) overall. Among those with secondary psychoses, patients' underlying conditions were revealed only by the workup in relation to the FEP in 16 of them, of which definitive or probable autoimmune encephalitis (n=5) and early-onset dementia (n=4) were the most common conditions uncovered. Conclusion The prevalence of secondary psychoses in our FEP cohort is lower than published international figures. Clinicians need to be aware of the suspicious clinical features suggestive of autoimmune encephalitis and early-onset dementia in FEP patients with otherwise unremarkable past history and toxicology test. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Joint Chinese University of Hong Kong - New Territories East Cluster Clinical Research Ethics Committee gvae ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 04, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Secondary causes among adult patients presenting with first-episode psychosis to acute medical settings in Hong Kong: A 10-Year retrospective study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Secondary causes among adult patients presenting with first-episode psychosis to acute medical settings in Hong Kong: A 10-Year retrospective study Steven Wai Ho Chau , Lam KW Lam , Matthew PM Yu , Yuen Cheuk Wong , Joseph CC Choi , Howan HW Leung medRxiv 2026.09.02.26362044; doi: https://doi.org/10.64898/2026.09.02.26362044 Share This Article: Copy Citation Tools Secondary causes among adult patients presenting with first-episode psychosis to acute medical settings in Hong Kong: A 10-Year retrospective study Steven Wai Ho Chau , Lam KW Lam , Matthew PM Yu , Yuen Cheuk Wong , Joseph CC Choi , Howan HW Leung medRxiv 2026.09.02.26362044; doi: https://doi.org/10.64898/2026.09.02.26362044 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (615) Allergy and Immunology (896) Anesthesia (327) Cardiovascular Medicine (4777) Dentistry and Oral Medicine (476) Dermatology (410) Emergency Medicine (645) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1617) Epidemiology (15853) Forensic Medicine (32) Gastroenterology (1196) Genetic and Genomic Medicine (6996) Geriatric Medicine (727) Health Economics (1059) Health Informatics (4999) Health Policy (1428) Health Systems and Quality Improvement (1742) Hematology (583) HIV/AIDS (1338) Infectious Diseases (except HIV/AIDS) (16251) Intensive Care and Critical Care Medicine (1163) Medical Education (665) Medical Ethics (151) Nephrology (721) Neurology (7208) Nursing (365) Nutrition (1074) Obstetrics and Gynecology (1233) Occupational and Environmental Health (1002) Oncology (3581) Ophthalmology (1039) Orthopedics (394) Otolaryngology (448) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1782) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5846) Public and Global Health (9705) Radiology and Imaging (2392) Rehabilitation Medicine and Physical Therapy (1436) Respiratory Medicine (1245) Rheumatology (635) Sexual and Reproductive Health (769) Sports Medicine (577) Surgery (769) Toxicology (107) Transplantation (303) Urology (287)
## Related Clinical Research

- [VR Headset Pupillometry Detects RAPD and Pathological Anisocoria: Study Results](https://medichelpline.com/clinical-feed/medrxiv-1-pupil-symmetry-and-swinging-light-test-performed-with-vr-headset-for-detection.md)
- [After Ultragenyx Angelman drug failure, experts say other antisense therapies still hold promise](https://medichelpline.com/clinical-feed/stat-news-1-stat-after-failure-of-angelman-syndrome-drug-experts-see-hope-in-other.md)
- [SniffCell: Cell-type-resolved somatic variant discovery from bulk long-read sequencing](https://medichelpline.com/clinical-feed/medrxiv-11-cell-type-resolved-somatic-variant-discovery-from-bulk-long-read-sequencing.md)
- [Diurnal and Seasonal Variation in Brain mu-Opioid and Dopamine D2 Receptor Signaling](https://medichelpline.com/clinical-feed/biorxiv-6-diurnal-and-seasonal-regulation-of-brain-mu-opioid-and-dopamine-d2-receptor.md)
- [FDA approves Zanvastro, the first disease-modifying drug for Alexander disease](https://medichelpline.com/clinical-feed/stat-news-0-stat-ionis-wins-fda-approval-for-first-drug-for-alexander-disease-a-rare-and.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.